BOLSA DE MADRID · GRFS
-0.82% · -$0.0600 · Vol 326.8K
Market closed · last close 4:00 PM ET · price as of 16:01:31 ET
Grifols SA

Grifols SA

Biotechnology
$7.27
Card
Relationship Map

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

Score not reportedVeridion does not publish a score-history trend for GRFS until the ticker has a real scored snapshot. No trend is implied for this page.Review methodology
NO SCORE SNAPSHOT COVERAGE
AI Analysis
Sovereign

Why is GRFS moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Catalyst calendar
Dated receipts for GRFS are being assembled.
About Grifols SA
Biotechnology
Listed since
2011
Employees
25K
Country
ES

Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$7.28
Day high
$7.36
Day low
$7.22
Previous close
$7.33
52W high
$10.85
-33.00% from high
52W low
$7.02
7% of range
Market cap
$5B
P/E
13.20×
EPS
$0.6735
Beta
1.00
Shares out
680.6M
Volume
326.8K
0.48× rel vol
Avg volume
674.8K
VWAP
$7.27
Price history computed in-house
1W
0.00%
1M
-1.76%
3M
-16.91%
1Y
-26.86%
YTD
-22.25%
SMA 50 $7.55 · below
SMA 200 $8.53 · below
52W position 7%
Veridion warehouse edge

Warehouse intelligence for GRFS.

Veridion Score
Not reported
Six-factor detail requires Sovereign.
Congress 30d
0
No recent disclosure on file.
Insider activity
See Form 4 panel below.
13F holders
None on file
Capital Web snapshots checked.
Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Related public evidence

Continue the GRFS research trail.

Relationship mapTrace receipt-backed holders and filings around GRFS.Congress disclosuresOpen receipt and filing context for GRFS.MethodologyReview score inputs, coverage rules, and limitations.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Source: Veridion methodology
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

Receipt-backed filing rows for GRFS are being assembled from the latest scheduled snapshot.

Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

GRFS contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for GRFS in this window.
Lobbying spend

GRFS lobbying filings, year to date.

Registered lobbying filings matched to Grifols SA.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for GRFS in this window.
Latest news · GRFS
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for GRFS.
Options
Sovereign unlock shows live options positioning for GRFS.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.